~1 spots leftby Oct 2025

Laser Ablation for Thyroid Cancer

Recruiting in Palo Alto (17 mi)
RM
Overseen byR. Michael Tuttle, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo Group
Prior Safety Data

Trial Summary

What is the purpose of this trial?

The purpose of this study is to explore whether percutaneous laser ablation (PLA) is a safe and effective alternative to removing papillary thyroid microcarcinoma (PTMC) with surgery.

Research Team

RM

R. Michael Tuttle, MD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Eligibility Criteria

This trial is for adults with a small thyroid cancer (≤13mm) called papillary thyroid microcarcinoma, who haven't spread to lymph nodes or beyond the thyroid capsule. It's for those who've declined just watching the tumor and have certain cancer cell characteristics confirmed by tests.

Inclusion Criteria

My other vocal cord works fine before the procedure.
The size of the maximum diameter of something should be 13 millimeters or less.
Your medical scans do not show any signs of cancer spreading to the lymph nodes.
See 5 more

Exclusion Criteria

My cancer has spread to my lymph nodes.
Pregnancy
Your thyroid lesion has more than 25% cysts in it.
See 2 more

Treatment Details

Interventions

  • Percutaneous Laser Ablation (PLA) (Procedure)
Trial OverviewThe study is testing percutaneous laser ablation (PLA), which uses lasers to destroy tumors without surgery, as a treatment option for removing tiny papillary thyroid cancers instead of traditional surgery.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Participants with papillary microcarcinoma (PTMC)Experimental Treatment1 Intervention
Participants with papillary microcarcinoma (PTMC) who have elected to proceed with thyroidectomy rather than an observational management approach will be considered as potential candidates for this trial.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+
Lisa M. DeAngelis profile image

Lisa M. DeAngelis

Memorial Sloan Kettering Cancer Center

Chief Medical Officer since 2021

MD from Columbia University

Selwyn M. Vickers profile image

Selwyn M. Vickers

Memorial Sloan Kettering Cancer Center

Chief Executive Officer since 2022

MD from Johns Hopkins University